Science Explorer Back to mapMap
Discussion
Researcher · Karus Therapeutics (United Kingdom) · United Kingdom

Stephen Shuttleworth

Stephen Shuttleworth publishes mostly in Molecular Biology, Oncology and Genetics, on topics such as PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research and Isotope Analysis in Ecology.

OpenAlex
World rank
#3,167,681
of 7,710,434 ranked researchers
Rank in United Kingdom
#213,634
of 367,258
Works
42
Citations
844
Citations per work
20.1
h-index
13
i10-index 14Top 59% in Molecular Biology
Stephen Shuttleworth

What does Stephen Shuttleworth research?

Stephen Shuttleworth's work is mostly in Medicine (20%), Biochemistry, Genetics and Molecular Biology (19%), Chemistry (6%).

Everything else: 21 works · 49.8% of their workHealth Sciences: 8 works · 20.1% of their workMedicine: 8 works · 20.1% of their workOncology: 4 works · 8.8% of their workGenetics: 3 works · 6.3% of their workPulmonary and Respiratory Medicine: 2 works · 5.0% of their workLife Sciences: 8 works · 18.8% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 18.8% of their workMolecular Biology: 8 works · 18.8% of their workPhysical Sciences: 5 works · 11.3% of their workChemistry: 3 works · 6.3% of their workOrganic Chemistry: 3 works · 6.3% of their workEnvironmental Science: 2 works · 5.0% of their workGlobal and Planetary Change: 2 works · 5.0% of their workTHEIR WORKStephenShuttleworth42works
Life Sciences19%Physical Sciences11%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2149.8%
    1. Medicine820.1%
    1. Biochemistry, Genetics and Molecular Biology818.8%
    1. Chemistry36.3%
    2. Environmental Science25.0%
  1. 1Molecular Biology19% of their works
  2. 2Oncology9% of their works
  3. 3Genetics6% of their works
  4. 4Organic Chemistry6% of their works
  5. 5Global and Planetary Change5% of their works
  6. 6Pulmonary and Respiratory Medicine5% of their works

Research topics

Which keywords describe Stephen Shuttleworth's research?

The keywords of their largest research topics: mTOR, Signaling, Chronic Lymphocytic Leukemia, Genomic Aberrations, Stable Isotopes, Trophic Position, Breast Cancer and CDK4/6 Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Signaling81 topic
  2. mTOR81 topic
  3. Chronic Lymphocytic Leukemia51 topic
  4. Genomic Aberrations51 topic
  5. Stable Isotopes41 topic
  6. Trophic Position41 topic
  7. Breast Cancer31 topic
  8. CDK4/6 Inhibitors31 topic
  9. Geochronology31 topic
  10. Mercury31 topic
  11. Toxicology31 topic
  12. Zircon31 topic
  13. Enzyme Regulation21 topic
  14. Molecularly Imprinted Polymers21 topic
  15. Nucleotide Metabolism21 topic
  16. Solid-Phase Microextraction21 topic

Where does Stephen Shuttleworth work?

Stephen Shuttleworth's main affiliation in the publication record is Karus Therapeutics (United Kingdom), United Kingdom.

How many publications and citations does Stephen Shuttleworth have?

OpenAlex counts 42 works and 844 citations for Stephen Shuttleworth, an h-index of 13, ranking #3,167,681 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stephen Shuttleworth. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.